Last week, Sarah Cannon, our global cancer institute, and HCA Midwest Health, Kansas City’s largest healthcare network, announced that they expanded their cancer collaboration through clinical research. By joining a global research network, HCA Midwest Health is now offering greater access to clinical trials for those facing cancer in the Kansas City region. “Clinical trials are an integral part of advancing the standard of cancer care, as today’s trials are tomorrow’s cutting-edge treatments,” said Dr. Howard A. “Skip” Burris, III, president of clinical operations and chief medical officer at Sarah Cannon. “By expanding our collaboration, we can provide patients in… Read more.